Managing long-term complications of left ventricular assist device therapy

Current Opinion in Cardiology

Volumn 26, Issue 3, 2011, Pages 237-244

  Potapov, Evgenij V ^a   Stepanenko, Alexander ^a   Krabatsch, Thomas ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

bleeding; complications; failure; infection; mechanical circulatory support; thrombosis; ventricular assist device

Indexed keywords

SILDENAFIL; TIROFIBAN;

ANTICOAGULATION; AORTA VALVE; ARTICLE; BLEEDING; BLOOD CLOTTING; DEVICE INFECTION; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART LEFT VENTRICLE ASSIST DEVICE; HEMOLYSIS; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOEMBOLISM; THROMBOSIS; TREATMENT FAILURE;

AORTIC VALVE; CATHETERIZATION; EQUIPMENT FAILURE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 79955071510     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328345af80     Document Type: Article

References (70)

1. Drews T, Dandel M, Krabatsch T, et al. Long-term mechanical circulatory support in 198 patients: largest single-center experience worldwide. ASAIO J 2010; 57:9-16.
2. John R, Mantz K, Eckman P, et al. Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transplant 2010; 29:1321-1329.
3. Pak SW, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010; 29:1172-1176.
4. Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010; 3:668-674.
5. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous- flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29 (4 Suppl):S1-S39.
6. Wieselthaler GM, O'Driscoll G, Jansz P, et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multiinstitutional trial. J Heart Lung Transplant 2010; 29:1218-1225.
7. Morshuis M, Schoenbrodt M, Nojiri C, et al. DuraHeart magnetically levitated centrifugal left ventricular assist system for advanced heart failure patients. Expert Rev Med Devices 2010; 7:173-183.
8. Warkentin TE, Greinacher A, Koster A. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg 2009; 87:1633-1640.
9. Zucker MJ, Sabnani I, Baran DA, et al. Cardiac transplantation and/or mechanical circulatory support device placement using heparin anticoagulation in the presence of acute heparin-induced thrombocytopenia. J Heart Lung Transplant 2010; 29:53-60.
10. Crow S, Chen D, Milano C 3rd, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010; 90:1263-1269.
11. Crow S, Milano C, Joyce L, et al. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J 2010; 56:441-445.
12. Meyer AL, Malehsa D, Bara C, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010; 3:675-681.
13. Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996; 112:1090-1097. (Pubitemid 26339283)
14. Klovaite J, Gustafsson F, Mortensen SA, et al. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuousflow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009; 53:2162-2167.
15. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010; 56:1207-1213.
16. Letsou GV, Shah N, Gregoric ID, et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005; 24:105-109. (Pubitemid 40094003)
17. Delgado R 3rd, Frazier OH, Myers TJ, et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant 2005; 24:231-233. (Pubitemid 40215604)
18. Rothenburger M, Wilhelm MJ, Hammel D, et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 2002; 106 (12 Suppl 1):I189-I192.
19. Thomas MD, Wood C, Lovett M, et al. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J Heart Lung Transplant 2008; 27:925-927. (Pubitemid 352024419)
20. Potapov EV, Stiller B, Hetzer R. Ventricular assist devices in children: current achievements and future perspectives. Pediatr Transplant 2007; 11:241-255. (Pubitemid 46570136)
21. Heilmann C, Geisen U, Benk C, et al. Haemolysis in patients with ventricular assist devices: major differences between systems. Eur J Cardiothorac Surg 2009; 36:580-584.
22. Bhamidipati CM, Ailawadi G, Bergin J, Kern JA. Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma. J Thorac Cardiovasc Surg 140:e7-e8.
23. Meyer AL, Kuehn C, Weidemann J, et al. Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 2008; 135:203-204.
24. Schulman AR, Martens TP, Russo MJ, et al. Effect of left ventricular assist device infection on posttransplant outcomes. J Heart Lung Transplant 2009; 28:237-242.
25. Garatti A, Giuseppe B, Russo CF, et al. Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy. J Heart Lung Transplant 2007; 26:956-959. (Pubitemid 47369200)
26. Allen JG, Weiss ES, Schaffer JM, et al. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant 2010; 29:278-285.
27. Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuousflow era. Ann Thorac Surg 2010; 90:1270-1277.
28. Schaffer JM, Allen JG, Weiss ES, et al. Infectious complications after pulsatileflow and continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2010. [Epub ahead of print]
29. Jafar M,Gregoric ID, Radovancevic R, et al. Urgent exchange of a HeartMate II left ventricular assist device after percutaneous lead fracture. ASAIO J 2009; 55:523-524.
30. Tigges-Limmer K, Schonbrodt M, Roefe D, et al. Suicide after ventricular assist device implantation. J Heart Lung Transplant 2010; 29:692-694.
31. Zierer A, Melby SJ, Voeller RK, et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007; 84:515-520. (Pubitemid 47069197)
32. Martin SI, Wellington L, Stevenson KB, et al. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact Cardiovasc Thorac Surg 2010; 11:20-23.
33. Kouretas PC, Burch PT, Kaza AK, et al. Management of deep wound complications with vacuum-assisted therapy after Berlin Heart EXCOR ventricular assist device placement in the pediatric population. Artif Organs 2009; 33:922-925.
34. Coyle LA, Ising MS, Gallagher C, et al. Destination therapy: one-year outcomes in patients with a body mass index greater than 30. Artif Organs 2010; 34:93-97.
35. Raymond AL, Kfoury AG, Bishop CJ, et al. Obesity and left ventricular assist device driveline exit site infection. ASAIO J 2010; 56:57-60.
36. Musci M, Loforte A, Potapov EV, et al. Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg 2008; 86:1236-1242.
37. Collard CD, Body SC. Endocarditis of a left ventricular assist device resulting in regurgitant flow. Anesth Analg 2003; 97:1548-1549. (Pubitemid 37310177)
38. Weitzel N, Puskas F, Cleveland J, et al. Left ventricular assist device outflow cannula obstruction by the rare environmental fungus Myceliophthora thermophila. Anesth Analg 2009; 108:73-75.
39. Birks EJ, Tansley PD, Yacoub MH, et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004; 23:964-969. (Pubitemid 39108107)
40. Chrysant GS, Horstmanshof DA, Snyder T, et al. Successful percutaneous management of acute left ventricular assist device stoppage. ASAIO J 2010; 56:483-485.
41. Pelenghi S, Colombo T, Montorsi E, et al. Failure and off-pump replacement of Incor LVAD system. ASAIO J 2009; 55:121-122.
42. Slaughter MS. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy. J Card Surg 2010; 25:490-494.
43. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg 2007; 133:1573-1580.
44. Slaughter MS, Myers TJ. Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects. J Card Surg 2010; 25:484-489.
45. Potapov EV, Stepanenko A, Dandel M, et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant 2008; 27:1275-1281.
46. Cantillon DJ, Tarakji KG, Kumbhani DJ, et al. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter- defibrillator. Heart Rhythm 2010; 7:466-471.
47. Andersen M, Videbaek R, Boesgaard S, et al. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 2009; 28:733-735.
48. Bedi M, Kormos R, Winowich S, et al. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007; 99:1151-1153. (Pubitemid 46562514)
49. Oswald H, Schultz-Wildelau C, Gardiwal A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail 2010; 12:593-599.
50. Refaat M, Chemaly E, Lebeche D, et al. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol 2008; 31:1246-1252.
51. Kamdar F, Boyle A, Liao K, et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 2009; 28:352-359.
52. Radovancevic B, Vrtovec B, de Kort E, et al. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant 2007; 26:815-818. (Pubitemid 47199072)
53. Saito S, Nishinaka T. Chronic nonpulsatile blood flow is compatible with normal end-organ function: implications for LVAD development. J Artif Organs 2005; 8:143-148. (Pubitemid 41464671)
54. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009; 87:1072-1078.
55. Ootaki C, Yamashita M, Ootaki Y, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg 2008; 136:150-158.
56. Busse R, Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res 1998; 35:73-84. (Pubitemid 28191773)
57. Etz CD, Welp HA, Tjan TD, et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 2007; 83:1697-1705. (Pubitemid 46616800)
58. Martin J, Siegenthaler MP, Friesewinkel O, et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 2004; 25:971-977. (Pubitemid 38622337)
59. Torre-Amione G, Southard RE, Loebe MM, et al. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant 2010; 29:195-200.
60. Kukucka M, Potapov E, Stepanenko A, et al. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg 2010. [Epub ahead of print]
61. Potapov EV, Weng Y, Jurmann M, et al. Bridging to transplantability with a ventricular assist device. J Thorac Cardiovasc Surg 2005; 130:930. (Pubitemid 41265762)
62. Mikus E, Stepanenko A, Krabatsch T, et al. Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. Eur J Cardiothorac Surg 2011; 39:310-316.
63. Garatti A, Bruschi G, Colombo T, et al. Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device. Am J Surg 2009; 197:710-714.
64. Goldstein DJ, Mullis SL, Delphin ES, et al. Noncardiac surgery in long-term implantable left ventricular assist-device recipients. Ann Surg 1995; 222: 203-207.
65. Gogas BD, Parissis JT, Filippatos GS, et al. Severe anaemia and subcapital femur fracture in a patient with Left Ventricular Assist Device Heart Mate II: the cardiologist's management of this rare patient. Eur J Heart Fail 2009; 11:806-808.
66. Kartha V, Gomez W, Wu B, Tremper K. Laparoscopic cholecystectomy in a patient with an implantable left ventricular assist device. Br J Anaesth 2008; 100:652-655. (Pubitemid 351774359)
67. Brown JB, Hallinan WM, Massey HT, et al. Does the need for noncardiac surgery during ventricular assist device therapy impact clinical outcome? Surgery 2009; 146:627-633; discussion 633-634.
68. Riha H, Netuka I, Kotulak T, et al. Anesthesia management of a patient with a ventricular assist device for noncardiac surgery. Semin Cardiothorac Vasc Anesth 2010; 14:29-31.
69. Lund JP, Drews T, Hetzer R, Reichart PA. Oral surgical management of patients with mechanical circulatory support. Int J Oral Maxillofac Surg 2002; 31:629-633.
70. Bunzel B, Laederach-Hofmann K, Wieselthaler GM, et al. Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: evaluation of patients and partners. Transplant Proc 2005; 37:1365-1368. (Pubitemid 40590889)